This CrowdStrike Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday
Avi Kapoor 6 months ago
NewsUpgradesPre-Market OutlookMarketsAnalyst RatingsTrading Ideas
Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Consider buying CRWD stock, here's what analysts think.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst Brian Lee upgraded Ramaco Resources Inc (NASDAQ:METC) from Sell to Neutral and raised the price target from $14 to $15. Ramaco Resources shares closed at $14.07 on Monday. See how other analysts view this stock.
- Keybanc analyst Eric Heath upgraded Crowdstrike Holdings Inc (NASDAQ:CRWD) from Sector Weight to Overweight and announced a $525 price target. CrowdStrike shares closed at $433.15 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Michael Ulz upgraded Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) from Equal-Weight to Overweight and raised the price target from $78 to $100. Arrowhead Pharma shares closed at $69.25 on Monday. See how other analysts view this stock.
Considering buying CRWD stock? Here’s what analysts think:
Photo via Shutterstock